Food Science and Technology

Professor Ben Montpetit leads study awarded $1M Keck Foundation grant

 

Researchers at the University of California, Davis, and the University of Alberta, Canada, have made preliminary discoveries about how Zika and hepatitis C viruses reproduce at the cellular level, providing new insight into a family of viruses that also includes West Nile and dengue. Now their cutting-edge research will be supported by a $1 million grant from the prestigious W.M. Keck Foundation. The foundation primarily focuses on pioneering efforts in the areas of medical research, science and engineering, and undergraduate education.

Distinguished Professor Charlie Bamforth to be honored at College Celebration

FST's Distinguished Professor of Brewing Sciences, Charlie Bamforth, is going to be honored with an Award of Distinction at it's 30th annual College Celebration on October 12.

The College of Agricultural and Environmental Sciences bestows the Awards of Distinction at College Celbration each year at harvest time to celebrate the advancement and accomplishments of our college and its impact on agriculture and the environment.  

View a write up on Charlie and the other award recipients at the link below.

Congratulations to Dr. Bamforth!

FST Professor David Mills featured in UCD News story on Bifidobacterium research

Dr. David Mills' research on the gut microbe Bifidobacterium is featured in a recent UCD News story.  The microbe can help keep antibiotic resistant infections at bay, according to his research.

Dr. Mills was a senior author on a research article called Bifidobacterial Dominance of the Gut in Early Life and Acquisition of Antimicrobial Resistance.  He was quoted, along with Post-doc Diana Taft, who was first author of the publication.

BASF collaborates with FST researchers on human milk oligosaccharides

The University of California, Davis (UC Davis), and BASF announced a collaboration to unlock new benefits of human milk oligosaccharides (HMOs). The long-term objective of this strategic research partnership is to develop and validate second-generation HMO molecules as potent bioactive compounds that can influence the establishment and maintenance of the gut microbiome and provide benefits beyond the gastrointestinal tract, such as brain health, for infants, children and adults.